EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway

N Bernardi, B F Neep, S Garibaldi, E Bianconi, J Aman, A Llucià-Valldeperas, D Sirello, G Zoppoli, F S de Man, P Ameri

Vascular Pharmacology · 2025

DOI: 10.1016/j.vph.2025.107464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von N Bernardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Genova, Genova, Italy. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Endothelial Cells, Pulmonary Artery, Nitric Oxide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non-coding RNA (lncRNA) may be involved in dysfunction of pulmonary artery endothelial cells (PAEC) and, thus, in pulmonary arterial hypertension (PAH) pathobiology. We screened the RNA expression profile of commercial human PAEC (hPAEC) exposed to increased hydrostatic pressure, and found that the lncRNA Down syndrome critical region 9 (DSCR9) was the most regulated transcript (log2FC 1.89 vs control). We confirmed by RT-qPCR that DSCR9 levels were higher in PAEC isolated from patients with idiopathic PAH (iPAH-PAEC), as well as in induced pluripotent stem cell-derived endothelial cells (iPSC-EC) from a patient with BMPR2-mutated PAH, than in relevant controls. Moreover, a re-analysis of the publicly available GSE117261 microarray dataset revealed that DSCR9 was upregulated in the lung tissue of PAH patients. In silico simulation indicated that DSCR9 would be mainly located in the nucleus and could interact with calcium/calmodulin-dependent protein kinase II beta (CAMK2B) and nitric oxide synthase 3 (NOS3, encoding eNOS). CAMK2B levels resulted 3.4-fold higher (p < 0.05) in iPAH-PAEC transfected with a DSCR9-GFP carrying plasmid than with a GFP-only-carrying one. A trend for higher NOS3 expression was also noted. GFP immunostaining was predominantly nuclear and cytoplasmic upon DSCR9-GFP or GFP-only transfection, respectively. CAMK2B and NOS3 mRNA were also higher in iPAH-PAEC than control-PAEC in basal conditions. Instead, variations in total and phosphorylated CAMK2B, eNOS, and NO synthesis were inconsistent. We conclude that DSCR9 is upregulated in PAH-related endothelial cell models and influences CAMK2B and NOS3 expression. Future studies are necessary to determine whether DSCR9 affects NO availability, including in PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingEndothelial CellsPulmonary ArteryNitric OxidePulmonary Arterial HypertensionFamilial Primary Pulmonary HypertensionHumansNitric Oxide Synthase Type IIICells, CulturedSignal TransductionBone Morphogenetic Protein Receptors, Type IICalcium-Calmodulin-Dependent Protein Kinase Type 2Induced Pluripotent Stem CellsCase-Control StudiesMale

Stichwörter der Autor:innen

CAMK2BEndothelialLong non-coding RNANitric oxideeNOS

Substanzen

RNA, Long NoncodingNitric Oxide Synthase Type IIINitric OxideNOS3 protein, humanBone Morphogenetic Protein Receptors, Type IICalcium-Calmodulin-Dependent Protein Kinase Type 2BMPR2 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Genova, Genova, Italy.
  • Amsterdam UMC Location Vrije Universiteit Amsterdam, PHEniX Laboratory, Department of Pulmonary Medicine, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam,…
  • IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Department of Internal Medicine, University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Department of Internal Medicine, University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: pietroameri@unige.it.

Zitieren

APA

Bernardi, N., Neep, B. F., Garibaldi, S., Bianconi, E., Aman, J., Llucià-Valldeperas, A., Sirello, D., Zoppoli, G., de Man, F. S., & Ameri, P. (2025). The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2025.107464

Vancouver

Bernardi N, Neep BF, Garibaldi S, Bianconi E, Aman J, Llucià-Valldeperas A, et al. The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2025.107464

BibTeX
@article{Bernardi2025,
  author = {Bernardi, N and Neep, B F and Garibaldi, S and Bianconi, E and Aman, J and Llucià-Valldeperas, A and Sirello, D and Zoppoli, G and de Man, F S and Ameri, P},
  title = {The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway},
  journal = {Vascular Pharmacology},
  year = {2025},
  doi = {10.1016/j.vph.2025.107464}
}
Kostenlos starten →